Status:
TERMINATED
Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Abdominal Organs - Lipodystrophy
Tumors
Eligibility:
All Genders
Up to 99 years
Brief Summary
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging an...
Detailed Description
Background: MRI is a constantly evolving imaging modality. Pulse sequences are often modified to improve their performance. However, many of these changes have not yet been approved by the FDA and th...
Eligibility Criteria
- INCLUSION CRITERIA:
- All patients undergoing MRI in the Clinical Center.
- Patients must be able to provide informed consents.
EXCLUSION CRITERIA:
- Contraindications to MRI.
- Inability to understand consent form or consent process and the absence of a suitable guardian.
- Adults who are or may not be able to consent
- Patients in whom the scan must be performed quickly, i.e. those patients under anesthesia, anxious patients, those requiring emergency medical care, or others in which it is deemed inappropriate to prolong a study.
- Refusal to Participate.
- Pregnant women and fetuses
- Neonates
Key Trial Info
Start Date :
June 18 1987
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2020
Estimated Enrollment :
49946 Patients enrolled
Trial Details
Trial ID
NCT00001219
Start Date
June 18 1987
End Date
June 3 2020
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892